Keystone Symposia Press Release on New Board Chair, Professor Juleen R. Zierath

For Immediate Release
Yvonne M. Psaila
Director of Marketing & Communications
Keystone Symposia on Molecular & Cellular Biology
(970) 262-2676

Keystone Symposia Board Elects New Chair, Professor Juleen R. Zierath

SILVERTHORNE, CO – July 2, 2010 – Keystone Symposia on Molecular and Cellular Biology is pleased to announce that Professor Juleen R. Zierath, Ph.D. is the new Chair of its Board of Directors effective July 1, 2010. Her three-year term will run through June 2013. She will replace Curtis C. Harris, M.D., Chief of the Laboratory of Human Carcinogenesis at the National Cancer Institute, National Institutes of Health, who has served as Chair since 2007 and will now become an emeritus board member.

An internationally recognized expert on diabetes research, Dr. Zierath is Professor of Molecular Medicine and Surgery at the Karolinska Institutet in Stockholm, Sweden. She has authored more than 150 published research papers and review articles. Her work focuses on cellular mechanisms underlying the development of insulin resistance in type 2 diabetes mellitus.

In 2001, Professor Zierath received the prestigious Minkowski Prize from the European Association for the Study of Diabetes (EASD). In 2006, she was appointed to the Nobel Assembly at Karolinska Institutet, and she is an adjunct member of the Nobel Committee which selects winners of the Nobel Prize in Physiology or Medicine. In 2009, she was elected a member of the Royal Swedish Academy of Sciences. She also serves as Editor of Diabetologia, published by Springer on behalf of EASD.

She received her Bachelor’s degree from the University of Wisconsin, her Master’s degree in Exercise Science from Ball State University and her Ph.D. in Physiology from Karolinska Institutet. She also completed a post-doctoral fellowship at Harvard Medical School before joining the faculty of the Karolinska Institutet in 1996.

Professor Zierath has served on Keystone Symposia’s Board of Directors since 2008 and on its Scientific Advisory Board since 2006. She has also presented her research at numerous Keystone Symposia scientific meetings and organized several including an April 2010 meeting on diabetes in Whistler, Canada.

Commented Professor Zierath, “I am delighted and honored to assume this leadership role at the helm of an organization that plays such a critical role in life science collaboration and discovery. As it approaches its 40th anniversary in 2012, Keystone Symposia is poised to contribute in even more significant ways by holding conferences in increasingly diverse life science areas and on a more global scale. It is exciting to help lead it in these new directions.”

Added James W. Aiken, Ph.D., Keystone Symposia’s Chief Executive Officer, “We could not ask for a better Chair than Professor Zierath. She is not only a first-class scientist, but also a truly dynamic individual who embodies the principles of scientific collaboration and transparency on which Keystone Symposia is based. I would also like to thank Dr. Curt Harris for his exemplary service and leadership as Chair of our Board, and we look forward to the benefit of his wisdom for years to come as an emeritus member.”

In addition to Professor Zierath’s appointment, Keystone Symposia has also appointed two new members to its Board for the fiscal year beginning July 1, 2010. They are Gary J. Nabel, M.D., Ph.D., Director of the Vaccine Research Center at NIAID, National Institutes of Health, and Terry J. Opgenorth, Ph.D., Chief Operating Officer of NeoTREX at Colorado State University in Fort Collins.

About Keystone Symposia on Molecular and Cellular Biology

Keystone Symposia on Molecular and Cellular Biology, a 501(c)3 educational nonprofit organization, has been conducting internationally renowned, open scientific conferences since 1972 and has been headquartered in Summit County, Colorado since 1990, when the organization left the University of California at Los Angeles. Annually, Keystone Symposia holds more than 50 meetings involving more than 13,000 scientists from around the world on topics ranging from cellular and molecular mechanisms to cancer, cardiovascular/metabolic disease, infectious disease, neurobiology and plant biology. Almost 40% of the attendees are students and post-doctoral fellows. Meetings are held in the US and Canada as well as, increasingly, in overseas locations that have so far included Australia, Austria, China, England, Ireland, Japan, Singapore, South Africa, Tanzania, Thailand and Uganda.

Keystone Symposia relies on the generous support of corporations, foundations, governments and individuals for approximately 30% of its annual budget.

More information on Keystone Symposia can be found at For more details about Keystone Symposia’s Board of Directors, visit